Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.44M 1.35M 1.24M 2.31M 157M 2.33M 16.26M 6.3M 80.11M 6.16M 6.02M 260M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.14M 6.71M 6.14M 11.46M 778M 11.55M 80.58M 31.22M 397M 30.52M 29.85M 1.29B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
1 day-50.00%
6 months+9,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0
Change 5-day change 1-year change 3-year change Capi.($)
-50.00%-.--%-.--%-.--% 3.65K
-1.64%+1.31%+52.46%+109.07% 1,043B
-0.01%+0.74%+54.51%+67.71% 649B
-0.05%+0.78%+19.09%+73.55% 469B
-0.25%+0.72%+33.97%+45.63% 355B
+0.98%+3.30%+19.63%+27.91% 270B
-1.91%+2.59%+8.09%+12.53% 262B
-1.01%+8.10%+41.99%+51.70% 222B
-0.85%+3.47%+34.56%+101.80% 189B
-2.53%-8.57%-34.17%-60.67% 175B
Average -5.10%+1.98%+23.01%+42.92% 363.3B
Weighted average by Cap. +0.24%+2.19%+35.33%+65.85%

Financials

2007 2008
Net sales 23.47M 20.61M 19.36M 17.72M 33.09M 2.25B 33.33M 233M 90.13M 1.15B 88.12M 86.18M 3.71B 25.96M 22.8M 21.41M 19.6M 36.61M 2.49B 36.87M 257M 99.7M 1.27B 97.48M 95.34M 4.11B
Net income -20.86M -18.32M -17.21M -15.75M -29.41M -2B -29.63M -207M -80.11M -1.02B -78.32M -76.6M -3.3B -4.01M -3.52M -3.3M -3.03M -5.65M -383M -5.69M -39.71M -15.39M -196M -15.04M -14.71M -634M
Net Debt 18.79M 16.51M 15.5M 14.19M 26.5M 1.8B 26.69M 186M 72.17M 918M 70.56M 69.01M 2.97B 6.49M 5.7M 5.35M 4.9M 9.15M 621M 9.22M 64.32M 24.92M 317M 24.36M 23.83M 1.03B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
155
  1. Stock Market
  2. Stocks
  3. SYVC Stock